By boosting innate immunity, researchers eradicate aggressive prostate cancer in mice
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils ...
Mar 8, 2017
0
3